PLG Nanoparticles Target Fibroblasts and MARCO+ Monocytes to Reverse Multiorgan Fibrosis
Xu D, Bhattacharyya S, Wang W, Ifergan I, Chiang Wong MA, Procissi D, Yeldandi A, Bale S, Marangoni RG, Horbinski C, Miller SD, Varga J. JCI Insight. February 1, 2022

Symptom Experience of Limited Cutaneous Systemic Sclerosis from the Patients’ Perspective: A Qualitative Study
Lescoat A, Murphy SL, Chen Y, Vann N, Del . Galdo F, Cella D, Buch MH, Khanna D. Seminars in Arthritis and Rheumatism. February 2022

Cognitive Difficulties in People with Systemic Sclerosis: A Qualitative Study
Chen Y, Lescoat A, Devine A, Khanna D, Murphy SL. Rheumatology. January 7, 2022

Systemic Sclerosis-Associated Interstitial Lung Disease: How to Incorporate Two Food and Drug Administration-Approved Therapies in Clinical Practice
Khanna D, Lescoat A, Roofeh D, Bernstein EJ, Kazerooni EA, Roth MD, Martinez F, Flaherty KR, Denton CP. Arthritis & Rheumatology. January 2022

Characterization of Humoral Response to COVID mRNA Vaccines in Multiple Sclerosis Patients on Disease Modifying Therapies
Ali A, Dwyer D, Wu Q, Wang Q, Dowling CA, Fox DA, Khanna D, Poland GA, Mao-Draayer Y. Vaccine. October 1, 2021

Hospitalisations Related to Systemic Sclerosis and the Impact of Interstitial Lung Disease. Analysis of Patients Hospitalised at the University of Michigan, USA
Sankar S, Habib M, Jaafar S, Nagaraja V, Roofeh D, Young A, Huang S, Khanna D. Clinical and Experimental Rheumatology. July 28, 2021

The Association Between Hand Disease Severity and Fatigue in Individuals with Systemic Sclerosis: A Systematic Review
Krause D, Poole JL, Khanna D, Murphy SL. Disability and Rehabilitation. July 12, 2021

Clinical Characteristics, Visceral Involvement, and Mortality in At-Risk or Early Diffuse Systemic Sclerosis: A Longitudinal Analysis of an Observational Prospective Multicenter US Cohort
Jaafar S, Lescoat A, Huang S, Gordon J, Hinchcliff M, Shah AA, Assassi S, Domsic R, Bernstein EJ, Steen V, Elliott S, Hant F, Castelino FV, Shanmugam VK, Correia C, Varga J, Nagaraja V, Roofeh D, Frech T, Khanna D. Arthritis Research & Therapy. June 14, 2021

Performance of the DETECT Algorithm for Pulmonary Hypertension Screening in a Systemic Sclerosis Cohort
Young A, Moles VM, Jaafar S, Visovatti S, Huang S, Vummidi D, Nagaraja V, McLaughlin V, Khanna D. Arthritis & Rheumatology. March 24, 2021

Genome-Wide Reduction in Chromatin Accessibility and Unique Transcription Factor Footprints in Endothelial Cells and Fibroblasts in Scleroderma Skin
Tsou PS, Palisoc PJ, Ali M, Khanna D, Sawalha AH. Arthritis & Rheumatology. February 14, 2021

Tocilizumab Prevents Progression of Early Systemic Sclerosis Associated Interstitial Lung Disease
Roofeh D, Lin CJF, Goldin J, Kim GH, Furst DE, Denton CP, Huang S, Khanna D; focuSSced investigators. Arthritis & Rheumatology. February 3, 2021

How Do Patients Define Raynaud’s Phenomenon? Differences Between Primary and Secondary Disease
Murphy SL, Lescoat A, Alore M, Hughes M, Pauling J, Sabbagh M, Khanna D. Clinical Rheumatology. January 24, 2021

Targeting CD38-Dependent NAD+ Metabolism to Mitigate Multiple Organ Fibrosis
Shi B, Wang W, Korman B, Kai L, Wang Q, Wei J, Bale S, Marangoni RG, Bhattacharyya S, Miller S, Xu D, Akbarpour M, Cheresh P, Proccissi D, Gursel D, Espindola-Netto JM, Chini CCS, de Oliveira GC, Gudjonsson JE, Chini EN, Varga J. iScience. January 22, 2021

UCLA Scleroderma Clinical Trials Consortium Gastrointestinal Tract 2.0 Reflux Scale Correlates with Impaired Esophageal Scintigraphy Findings in Systemic Sclerosis
Abignano G, Mennillo GA, Lettieri G, Temiz Karadag D, Carriero A, Padula AA, Del Galdo F, Khanna D, D'Angelo S. The Journal of Rheumatology. January 15, 2021

Lymphocyte Subset Abnormalities in Early Diffuse Cutaneous Systemic Sclerosis
Fox DA, Lundy SK, Whitfield ML, Berrocal V, Campbell P, Rasmussen S, Ohara R, Stinson A, Gurrea-Rubio M, Wiewiora E, Spino C, Bush E, Furst D, Pillai S, Khanna D. Arthritis Research & Therapy. January 6, 2021

Epigenetics in Bone and Joint Disorders
Altorok, N., Nagaraja, V., & Kahaleh, B. Medical Epigenetics, 2021, Chapter 14, pp. 251-278. 

Development of a Musculoskeletal Ultrasound Protocol to Examine Upper Extremity Rehabilitation Outcomes in Systemic Sclerosis
Murphy SL, Krause D, Roll SC, Gandikota G, Barber M, Khanna D. Journal of Diagnostic Medical Sonography. November 22, 2020

Large-Scale Characterization of Systemic Sclerosis Serum Protein Profile: Comparison to Peripheral Blood Cell Transcriptome and Correlations with Skin/Lung Fibrosis
Bellocchi C, Ying J, Goldmuntz EA, Keyes-Elstein L, Varga J, Hinchcliff ME, Lyons MA, McSweeney P, Furst DE, Nash R, Crofford LJ, Welch B, Goldin JG, Pinckney A, Mayes MD, Sullivan KM, Assassi S. Arthritis & Rheumatology. November 1, 2020

Fatigue Predicts Future Reduced Social Participation, Not Reduced Physical Function or Quality of Life in People with Systemic Sclerosis
Murphy SL, Whibley D, Kratz AL, Poole JL, Khanna D. Journal of Scleroderma and Related Disorders. October 18, 2020

Considerations for a Combined Index for Limited Cutaneous Systemic Sclerosis to Support Drug Development and Improve Outcomes
Lescoat A, Murphy SL, Roofeh D, Pauling J, Hughes M, Sandler R, Zimmermann F, Wessel R, Townsend W, Chung L, Denton CP, Merkel PA, Steen V, Allanore Y, Del Galdo F, Godard D, Cella D, Farrington S, Buch MH, Khanna D. Journal of Scleroderma and Related Disorders. October 5, 2020

Faculty Publications

Learn More